Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1996-03-04
1998-11-03
Jones, W. Gary
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
435 6, 435 912, C12N 1500, C12Q 168, C12P 1934
Patent
active
058307214
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method for the production of polynucleotides conferring a desired phenotype and/or encoding a protein having an advantageous predetermined property which is selectable. In an aspect, the method is used for generating and selecting nucleic acid fragments encoding mutant proteins.
2. Description of the Related Art
The complexity of an active sequence of a biological macromolecule, e.g. proteins, DNA etc., has been called its information content ("IC"; 5-9). The information content of a protein has been defined as the resistance of the active protein to amino acid sequence variation, calculated from the minimum number of invariable amino acids (bits) required to describe a family of related sequences with the same function (9, 10). Proteins that are sensitive to random mutagenesis have a high information content. In 1974, when this definition was coined, protein diversity existed only as taxonomic diversity.
Molecular biology developments such as molecular libraries have allowed the identification of a much larger number of variable bases, and even to select functional sequences from random libraries. Most residues can be varied, although typically not all at the same time, depending on compensating changes in the context. Thus a 100 amino acid protein can contain only 2,000 different mutations, but 20.sup.100 possible combinations of mutations.
Information density is the Information Content/unit length of a sequence. Active sites of enzymes tend to have a high information density. By contrast, flexible linkers in enzymes have a low information density (8).
Current methods in widespread use for creating mutant proteins in a library format are error-prone polymerase chain reaction (11, 12, 19) and cassette mutagenesis (8, 20, 21, 22, 40, 41, 42), in which the specific region to be optimized is replaced with a synthetically mutagenized oligonucleotide. In both cases, a `mutant cloud` (4) is generated around certain sites in the original sequence.
Error-prone PCR uses low-fidelity polymerization conditions to introduce a low level of point mutations randomly over a long sequence. Error prone PCR can be used to mutagenize a mixture of fragments of unknown sequence. However, computer simulations have suggested that point mutagenesis alone may often be too gradual to allow the block changes that are required for continued sequence evolution. The published error-prone PCR protocols do not allow amplification of DNA fragments greater than 0.5 to 1.0 kb, limiting their practical application. Further, repeated cycles of error-prone PCR lead to an accumulation of neutral mutations, which, for example, may make a protein immunogenic.
In oligonucleotide-directed mutagenesis, a short sequence is replaced with a synthetically mutagenized oligonucleotide. This approach does not generate combinations of distant mutations and is thus not combinatorial. The limited library size relative to the vast sequence length means that many rounds of selection are unavoidable for protein optimization. Mutagenesis with synthetic oligonucleotides requires sequencing of individual clones after each selection round followed by grouping into families, arbitrarily choosing a single family, and reducing it to a consensus motif, which is resynthesized and reinserted into a single gene followed by additional selection. This process constitutes a statistical bottleneck, it is labor intensive and not practical for many rounds of mutagenesis.
Error-prone PCR and oligonucleotide-directed mutagenesis are thus useful for single cycles of sequence fine tuning but rapidly become limiting when applied for multiple cycles.
Error-prone PCR can be used to mutagenize a mixture of fragments of unknown sequence (11, 12). However, the published error-prone PCR protocols (11, 12) suffer from a low processivity of the polymerase. Therefore, the protocol is unable to result in the random mutagenesis of an average-sized gene. This inability limits the practical application of er
REFERENCES:
patent: 4994368 (1991-02-01), Goodman et al.
patent: 5043272 (1991-08-01), Hartley
patent: 5093257 (1992-03-01), Gray
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5279952 (1994-01-01), Wu
patent: 5521077 (1996-05-01), Kholsa et al.
patent: 5605793 (1997-02-01), Stemmer
patent: 5652116 (1997-07-01), Grandi et al.
Stemmer, "DNA Shuffling by Random Fragmentation and Reassembly: In Vitro Recombination for Molecular Evolution," Proc. Natl. Acad. Sci., USA, vol. 91, Issued Oct. 1994, pp. 10747-10751.
Feinberg and Vogelstein, Anal. Biochem. 132:pp. 6-13 (1983).
Horton et al., Gene 77: pp. 61-68 (1989).
Ho et al., Gene 77: pp. 51-59 (1989).
Pharmacia Catalog pp. 70-71 (1993 Edition).
Jones et al., BioTechniques 12(4): pp. 528-534 (1992).
Calogero Sabina et al., "In Vivo Recombination and the Production of Hybrid Genes," Microbiology letters, 1192, vol. 97, pp. 41-44.
Caren Robert et al., "Efficient Sampling of Protein Sequence Space for Multiple Mutants," Biotechnology, May 12, 1994, vol. 12, pp. 517-520.
Delagrave Simon et al., "Recursive Ensemble Mutagenesis," Protein Engineering, 1993, vol. 6, No. 3, pp. 327-331.
Meyerhans Andreas et al., "DNA Recombination during PCR," Nucleic Acids Research, 1990, vol. 18, No. 7, pp. 1687-1691.
Beaudry et al., "Directed Evolution of an RNA Enzyme," Science, vol. 257, Issued Jul. 31, 1992, pp. 635-641.
Berger et al., "Phoenix Mutagenesis: One-Step Reassembly of Multiply Cleaved Plasmids With Mixtures of Mutant and Wild-Type Fragments," Anal. Biochem., vol. 214, Issued 1993, pp. 571-579, see pp. 571-578.
Berkhout et al., "In Vivo Selection of Randomly Mutated Retroviral Genomes," Nucleic Acids Research, vol. 21, No. 22, Issued 1993, pp. 5020-5023.
E. Coli, "Formation of Genes Coding for Hybrid Proteins by Recombination Between related, cloned Genes in Vivo," Nucleic Acids Research, vol. 11, No. 16, 1983, pp. 5661-5669.
Leung et al., "A Method For Random Mutagenesis of a Defined DNA Segment Using a Modified Polymerase Chain Reaction," Techniques, vol. 1, Issued Aug. 198.
Marks James et al., "By-Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling," Bio/Technology, vol. 10, Issued Jul. 1992, pp. 779-782.
Pompon Denis et al., "Protein Engineering by cDNA Recombination in Yeasts: Shuffling of Mamalian Cytochrome P-450 functions," Gene, 1989, vol. 83, pp. 15-24.
Stemmer et al., "Rapid Evolution of a Protein in vitro by DNA Shuffling" Nature 370:389-391 (1994).
Beaudry et al., "Directed Evolution of an RNA Enzyme" Science 257:635-641 (1992).
Arkin et al., "An Algorithm for Protein Engineering: Simulations of Recursive Ensemble Mutagenesis" Proc. Natl. Acad. Sci. USA 89:7811-7811 (1992).
Cadwell et al., "Randomization of Genes by PCR Mutagenesis" PCR Methods and Applications 2:28-33 (1992).
Hermes et al., "Searching Sequence Space by Definably Random Mutagenesis: Improving the Catalytic Potency of an Enzyme" Proc. Natl. Acad. Sci. USA 87:696-700 (1990).
Kim et al., "Human Immunodeficiency Virus Reverse Transcriptase" The Journal of Biological Chemistry 271, No. 9 pp. 4872-4878 (1996).
Oliphant et al., "Cloning of Random-Sequence Oligodeoxynucleotides" Gene 44:177-183 (1988).
Reidhaar-Olson et al., "Combinatorial Cassette Mutagenesis as a Probe of the Informational Content of Protein Sequences" Science 241:53 57 (1988).
Roa et al., Recombination and Polymerase Error Facilitate Restoration of Infectivity in Brome Mosaic Virus Journal of Virology No. 2 67:969-979 (1993).
Stemmer et al., "Selection of an Active Single Chain FV Antibody from a Protein Linker Library Prepared by Enzymatic Inverse PCR" Biotechniques Biotechniques 14:256-265 (1992).
Crameri Andreas
Stemmer Willem P. C.
Affymax Technologies N.V.
Jones W. Gary
Whisenant Ethan
LandOfFree
DNA mutagenesis by random fragmentation and reassembly does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA mutagenesis by random fragmentation and reassembly, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA mutagenesis by random fragmentation and reassembly will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-688333